PDE4B Inhibitor Market Set to Witness Significant Growth Driven by Rising Chronic Disease Burden, Pipeline Advancements, and Multi-Indication Potential Through 2034
PDE4B Inhibitor Market Summary The Phosphodiesterase 4B (PDE4B) inhibitor market in the 7MM is projected to grow at a significant CAGR by 2034 across the leading countries (US, EU4, UK, and Japan). PDE4B inhibitors represent a promising class of targeted therapies with